Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $0.17 Analyst target: $4.00 Upside: 2246.04%
Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. The company is headquartered in Rockville, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.